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Abstract Cultured mouse peritoneal macrophages release large numbers of ~30-nm cholesterol-
rich particles. Here, we show that those particles represent fragments of the plasma membrane
that are pulled away and left behind during the projection and retraction of filopodia and
lamellipodia. Consistent with this finding, the particles are enriched in proteins found in focal
adhesions, which attach macrophages to the substrate. The release of particles is abolished by
blocking cell movement (either by depolymerizing actin with latrunculin A or by inhibiting myosin II
with blebbistatin). Confocal microscopy and NanoSIMS imaging studies revealed that the plasma
membrane–derived particles are enriched in ‘accessible cholesterol’ (a mobile pool of cholesterol
detectable with the modified cytolysin ALO-D4) but not in sphingolipid-sequestered cholesterol [a
pool detectable with ostreolysin A (OlyA)]. The discovery that macrophages release cholesterol-rich
particles during cellular locomotion is likely relevant to cholesterol efflux and could contribute to
extracellular cholesterol deposition in atherosclerotic plaques.
DOI: https://doi.org/10.7554/eLife.50231.001
Introduction
A key function of macrophages is to engulf and digest cellular debris. The cholesterol in the debris
can be esterified and stored in cytosolic lipid droplets (Brown et al., 1980), thereby avoiding toxicity
associated with an accumulation of free cholesterol, but macrophages ultimately must dispose of the
surplus cholesterol, a process generally referred to as ‘cholesterol efflux’ (Rosenson et al., 2012;
Tall et al., 2002; Rothblat and Phillips, 2010; Adorni et al., 2007). One mechanism for cholesterol
efflux involves transferring free cholesterol to high density lipoproteins (HDL), a process that is facili-
tated by ABC transporters (Rosenson et al., 2012; Tall et al., 2002; Rothblat and Phillips, 2010;
Yvan-Charvet et al., 2010; Westerterp et al., 2014; Duong et al., 2006). A deficiency of ABCA1
interferes with cholesterol efflux by macrophages, leading to an accumulation of foam cells (macro-
phages containing numerous cholesterol ester droplets) in tissues (Brooks-Wilson et al., 1999;
Bodzioch et al., 1999; Clee et al., 2001; Rust et al., 1999). Another potential mechanism for cho-
lesterol efflux by macrophages is the release of cholesterol-rich particles from the plasma mem-
brane. Using a cholesterol-specific monoclonal antibody and immunocytochemical approaches, the
laboratory of Howard Kruth reported that cultured human monocyte–derived macrophages release
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‘cholesterol microdomains’ (varying in size but as large as several hundred nm) onto the surrounding
substrate (Jin et al., 2016; Freeman et al., 2014; Ong et al., 2010; Jin et al., 2015; Jin et al.,
2018). The release of these microdomains was reduced by decreasing the expression of ABC trans-
porters (Jin et al., 2016; Freeman et al., 2014; Jin et al., 2015; Jin et al., 2018). Recently, we dem-
onstrated, by scanning electron microscopy (SEM), that large numbers of ~30-nm vesicular particles
were released from the plasma membrane of mouse peritoneal macrophages and a mouse macro-
phage cell line by a process that morphologically resembles ‘budding.’ The plasma membrane–
derived particles were enriched in ‘accessible cholesterol’ (He et al., 2018), a mobile pool of choles-
terol that can be detected by ALO-D4, a modified cholesterol-binding cytolysin (Gay et al., 2015).
The cholesterol content of the particles could be increased by loading macrophages with cholesterol
or by treating the cells with a liver X receptor (LXR) agonist, and the cholesterol content of the par-
ticles could be depleted with HDL (He et al., 2018).
The SEM studies by He and coworkers (He et al., 2018) demonstrated that the particles released
by macrophages are derived from the plasma membrane, but the mechanism was unclear. One pos-
sibility is that the budding of particles from the plasma membrane was driven by shuttling choles-
terol into plasma membrane microdomains, causing outward ballooning of a localized segment of
the plasma membrane and ultimately to the release of a vesicular particle. A second possibility, men-
tioned by He and coworkers (He et al., 2018) but not pursued, was that the particles represented
segments of the macrophage plasma membrane that had been affixed to the substrate but then
‘torn away and left behind’ during movement of filopodia and lamellipodia.
In the current study, we used live-cell microscopy and SEM, along with proteomic studies, to
explore the mechanism for the release of particles from the plasma membrane of macrophages. We
also used super-resolution fluorescence microscopy and NanoSIMS imaging, in combination with
two different cholesterol-binding proteins (one specific for ‘accessible cholesterol’ and the other for
sphingomyelin-sequestered cholesterol), to examine the cholesterol pools within the plasma mem-
brane–derived particles released by macrophages.
Results
Macrophages release plasma membrane–derived particles during the
movement of filopodia and lamellipodia
In the current studies, we again found that particles are released from macrophage filopodia and
lamellipodia onto the surrounding substrate by a process that resembles budding (Figure 1—figure
supplement 1). Because the released particles remain adherent to the substrate, we suspected that
the particles might represent fragments of the plasma membrane that were affixed to the underlying
substrate but then pulled away and left behind during movement of filopodia/lamellipodia. To
explore this idea, we plated mouse peritoneal macrophages onto gridded glass-bottom dishes and
recorded images of cells by live-cell microscopy (Figure 1—videos 1–2), making it possible to visual-
ize the projection and retraction of filopodia/lamellipodia. The same cells were then fixed and
imaged by SEM. Lawns of ~30-nm particles were present on the substrate surrounding macro-
phages, generally at the lagging pole of the cell and invariably where we had observed, by live-cell
imaging, the extension and retraction of filopodia/lamellipodia (Figure 1, Figure 1—videos 1–2).
To determine whether the extension and retraction of filopodia/lamellipodia are required for par-
ticle release, cell movement was blocked by treating macrophages with an actin-depolymerizing
agent (latrunculin A) or a myosin II inhibitor (blebbistatin). Live-cell imaging revealed that the drug-
treated macrophages were unable to project and retract filopodia/lamellipodia (Figure 2—videos
1–6). Macrophages were incubated with latrunculin A or blebbistatin in suspension for 1 hr (‘pre-
treatment’) and then plated onto poly-D-lysine–coated silicon wafers and incubated with the drugs
overnight (Figure 2). Both latrunculin A and blebbistatin abolished particle release from ‘pre-treat-
ment’ macrophages (Figure 2A–B). Other macrophages were allowed to adhere to the substrate for
1 hr before initiating drug treatment (‘post-adherence’) (Figure 2A–B). In latrunculin A–treated
‘post-adherence’ macrophages, a circumferential ring of particles was left behind on the substrate as
the cell retracted with actin depolymerization (Figure 2A). Blebbistatin eliminated particle release in
post-adherence cells (Figure 2B). Macrophages treated with vehicle alone (DMSO) released large
numbers of particles onto the surrounding substrate (Figure 2A–B). As an additional control,
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macrophages that had been incubated with drugs overnight were washed and incubated for an
additional 18 hr without drugs. In the absence of the drugs, the morphology of the cells returned to
normal and particle release resumed, with numerous particles appearing on the surrounding sub-
strate (Figure 2A–B).
To determine if the particles that are released during the projection and retraction of lamellipodia
contain ‘accessible cholesterol’ (a mobile pool of cholesterol that is not sequestered by sphingoli-
pids), we performed live-cell imaging of RAW 264.7 macrophages (Figure 3—videos 1–2) and then
incubated the cells with [15N]ALO-D4. The macrophages were then processed for SEM and Nano-
SIMS imaging. The lawn of particles around macrophages, visible by SEM, was enriched in 15N, as
revealed by NanoSIMS imaging (Figure 3). Of note, the degree of 15N enrichment was greater in
the lawn of particles than on the plasma membrane covering the macrophage cell body or macro-
phage filopodia (Figure 3).
Macrophage particles contain plasma membrane proteins
Given that the particles on the substrate were derived from the plasma membrane, we suspected
that they would contain plasma membrane proteins. Two findings lent credence to our suspicion.
First, after biotinylating cell-surface proteins of macrophages with Sulfo-NHS-SS-biotin, the lawn of
Figure 1. Macrophages release plasma membrane–derived particles onto the substrate during extension and
retraction of filopodia and lamellipodia, as judged by correlative live-cell imaging and SEM. Cells were plated
onto poly-D-lysine–coated gridded glass-bottom Petri dishes, and videos were recorded for 24 hr at 5 min
intervals (see Figure 1—videos 1–2). The ‘Live cell’ images show the final frame of the videos. The imaging of
cells by SEM made it possible to visualize a lawn of particles that had been released onto the substrate during the
projection and retraction of filopodia/lamellipodia. The red boxed region in the live-cell image and in the low-
magnification SEM image is shown in the SEM image on the far right. Three independent experiments were
performed; representative images are shown. Scale bar, 5 mm.
DOI: https://doi.org/10.7554/eLife.50231.002
The following video and figure supplement are available for figure 1:
Figure supplement 1. Macrophages release particles from the plasma membrane of filopodia and lamellipodia by
a process that resembles budding.
DOI: https://doi.org/10.7554/eLife.50231.003
Figure 1—video 1. Mouse peritoneal macrophages release vesicular particles onto the surrounding substrate dur-
ing the extension and retraction of filopodia and lamellipodia.
DOI: https://doi.org/10.7554/eLife.50231.004
Figure 1—video 2. Shows a macrophage imaged by SEM in the bottom row of Figure 1.
DOI: https://doi.org/10.7554/eLife.50231.005
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particles surrounding macrophages could be detected with fluorescent streptavidin (colocalizing
with fluorescently labeled ALO-D4, which binds ‘accessible cholesterol’) (Figure 4A). Also, by SEM,
streptavidin-conjugated 40-nm gold nanoparticles bound to both macrophages and to the surround-
ing particles (Figure 4B). There was no binding of the gold nanoparticles to non-biotinylated macro-
phages (Figure 4—figure supplement 1). Second, by NanoSIMS analyses, the lawn of particles
outside macrophages contained 14N and 32S (as well as accessible cholesterol, detectable with [15N]
ALO-D4) (Figure 4—figure supplement 2). In light of these findings, we prepared both particle and
Figure 2. Inhibiting macrophage movement with latrunculin A or blebbistatin abolishes particle release onto the surrounding substrate. Scanning
electron micrographs (SEMs) of mouse peritoneal macrophages that had been treated with latrunculin A (A) or blebbistatin (B). Macrophages were
treated with latrunculin A, blebbistatin, or vehicle alone (DMSO) overnight; the drug treatments were initiated when the cells were in suspension 1 h
before plating (’pre-treatment’) or 1 h after adherence to the substrate (’post-adherence’). Macrophages treated with vehicle alone (DMSO) released
particles onto the substrate. No particles were visible on the substrate in cells that had been pre-treated with latrunculin A or blebbistatin—or in the
blebbistatin post-adherence cells. In the latrunculin A post-adherence cells, a circumferential ring of particles was observed around cells. Latrunculin A
and blebbistatin were removed from some dishes after the overnight incubation, and the cells were incubated for an additional 18 h without drugs.
After removing the drugs, the release of particles onto the substrate resumed. Four independent experiments were performed; representative images
are shown. Scale bars for images on the left in each panel are 4 mm; scale bars for the images in the middle and right are 1 mm.
DOI: https://doi.org/10.7554/eLife.50231.006
The following videos are available for figure 2:
Figure 2—video 1. Treatment of mouse peritoneal macrophages with latrunculin A or blebbistatin prevent projection and retraction of filopodia/
lamellipodia.
DOI: https://doi.org/10.7554/eLife.50231.007
Figure 2—video 2. Shows macrophages treated with vehicle (DMSO) alone.
DOI: https://doi.org/10.7554/eLife.50231.008
Figure 2—video 3. Shows macrophages treated with latrunculin A.
DOI: https://doi.org/10.7554/eLife.50231.009
Figure 2—video 4. Shows macrophages treated with latrunculin A.
DOI: https://doi.org/10.7554/eLife.50231.010
Figure 2—video 5. Shows a macrophage treated with blebbistatin.
DOI: https://doi.org/10.7554/eLife.50231.011
Figure 2—video 6. Shows macrophages treated with blebbistatin.
DOI: https://doi.org/10.7554/eLife.50231.012
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plasma membrane preparations from RAW 264.7 mouse macrophages (see Materials and methods)
for shotgun proteomics. By negative-stain transmission electron microscopy (TEM), the size of par-
ticles in the particle preparation (Figure 5—figure supplement 1B) was similar to particles in the
SEM images (Figure 5—figure supplement 1A). TEM images of the plasma membrane preparations
revealed aggregates of membranous material (Figure 5—figure supplement 1B). Proteomic studies
on three independent particle and plasma membrane preparations revealed that both were enriched
in focal adhesion proteins and cytoskeletal components (Figure 5A–B). When analyses were con-
fined to the top 75th percentile of proteins by spectral count, we identified 653 proteins in the parti-
cle preparations and 715 proteins in the plasma membrane preparations, with 502 proteins in
common (Figure 5C). The top 15 focal adhesion–related proteins, as annotated by Gene Ontology,
were found in both the particle and the plasma membrane preparations, but the majority of those
proteins were relatively more abundant in the particle preparations (Figure 5D).
Figure 3. Correlative live-cell, scanning electron microscopy (SEM), and NanoSIMS imaging, revealing that particles released onto the substrate during
movement of filopodia and lamellipodia are enriched in accessible cholesterol. RAW 264.7 macrophages were plated onto iridium- and poly-D-lysine–
coated gridded glass-bottom Petri dishes. Videos were recorded for 24 hr at 5 min intervals (see Figure 3—videos 1–2). The ‘Live cell’ images in this
figure show the final frame of the videos, with the white arrows pointing to the cells that were subsequently visualized by SEM and NanoSIMS. After
live-cell imaging, cells were incubated with [15N]ALO-D4 (a modified cytolysin that binds to ‘accessible cholesterol’). The same cells that were imaged
by live-cell imaging were subsequently imaged by SEM (to visualize particles) and NanoSIMS (to visualize [15N]ALO-D4 binding). The particles left
behind on the substrate during movement of lamellipodia and filopodia bound [15N]ALO-D4 avidly. 12C14N– NanoSIMS images were used to visualize
cell morphology; the 15N/14N images show 15N enrichment (i.e., binding of [15N]ALO-D4). The boxed region in the SEM and NanoSIMS images is
shown at higher magnification in the ‘HM-SEM’ image, providing definition of individual particles. 15N enrichment was ~twofold higher in the
macrophage particles than on the plasma membrane over the cell body and the filopodia. Two independent experiments were performed;
representative images are shown. Quantification of 15N/14N ratios were performed on the cell body and macrophage particles [25 distinct regions of
the cell body, filopodia, and particles (20 pixels in diameter) were circled on the 12C14N– image, followed by calculation of 15N/14N ratios in each
region]. Images from six macrophages were used for the quantification. Graph shows the mean and standard deviation of the fold change of 15N
enrichment in particles and filopodia, normalized to the macrophage cell body. **p<0.001. Scale bar, 2 mm.
DOI: https://doi.org/10.7554/eLife.50231.013
The following videos are available for figure 3:
Figure 3—video 1. RAW 264.7 macrophages release particles during projection and retraction of lamellipodia.
DOI: https://doi.org/10.7554/eLife.50231.014
Figure 3—video 2. Shows a macrophage imaged by SEM and NanoSIMS in the bottom row of Figure 3.
DOI: https://doi.org/10.7554/eLife.50231.015
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Figure 4. Particles released from the plasma membrane of biotinylated mouse peritoneal macrophages can be detected with streptavidin and ALO-D4
(a cytolysin that binds to the accessible pool of cholesterol). (A) Biotinylated macrophage particles can be detected with fluorescently labeled
streptavidin as judged by confocal microscopy. Macrophages in suspension were biotinylated with Sulfo-NHS-SS-biotin. After plating the cells onto
glass coverslips and incubating the cells in macrophage growth medium containing 10% FBS, the cells were washed and then incubated with Atto
Figure 4 continued on next page
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Inhibition of focal adhesion disassembly increases release of particles
Focal adhesions are macromolecular assemblies that link the actin cytoskeleton inside cells to the
extracellular substrate (Lauffenburger and Horwitz, 1996; Burridge and Fath, 1989). The presence
of focal adhesion proteins and cytoskeletal proteins in the particles is consistent with the observation
that particles are released when small segments of the plasma membrane are pulled away and left
behind during movement of filopodia/lamellipodia. We suspected that particle release might be
increased by interfering with disassembly of focal adhesions. Focal adhesion kinase (FAK) is impor-
tant for focal adhesion disassembly. Phosphorylation of Tyr-397 in FAK is one of the events in initiat-
ing focal adhesion disassembly (Hamadi et al., 2005; Nagano et al., 2012), and that step can be
blocked with an FAK inhibitor. In macrophages treated with an FAK inhibitor, the filopodia and
lamellipodia remain mobile (Figure 6—videos 1–2). In four different experiments, the lawn of par-
ticles surrounding macrophages appeared larger in cells treated with an FAK inhibitor (Figure 6—
figure supplement 1). Indeed, the lawns of particles outside of FAK inhibitor–treated macrophages
were ~twice the size of the macrophage cell body, whereas they were only ~40% as large as the cell
body in DMSO-treated macrophages (10 macrophages were analyzed per group). Cholesterol-
loaded macrophages (loaded with an incubation with acetylated low-density lipoproteins) retained
their mobility, as judged by live-cell imaging (Figure 6—videos 3–4), and lawns of particles were
present on the substrate surrounding cholesterol-loaded cells (Figure 6—figure supplement 1).
When cholesterol-loaded macrophages were treated with an FAK inhibitor, large lawns of particles
were observed around almost every cell (Figure 6—figure supplement 1).
Macrophage-derived particles are enriched in accessible cholesterol but
not sphingolipid-sequestered cholesterol
Next, we asked whether the particles surrounding macrophages were enriched in sphingomyelin-
sequestered cholesterol. Initially, we used super-resolution microscopy to compare the binding of
ALO-D4 (which binds to accessible cholesterol) (Gay et al., 2015) and OlyA (which binds to sphingo-
myelin-bound cholesterol) (Endapally et al., 2019) to macrophages and to particles on the sur-
rounding substrate. Mouse peritoneal macrophages were plated onto glass-bottom MatTek dishes
and incubated in medium containing an FAK inhibitor or vehicle alone (DMSO). After 24 hr, the cells
were incubated at 4˚C with Alexa Fluor 488–labeled [15N]ALO-D4 and Atto 647N–labeled [13C]OlyA.
Stimulated emission depletion (STED) microscopy revealed avid ALO-D4, but not OlyA, binding to
the lawn of particles around macrophages (Figure 6). The lawn of particles surrounding cells was
larger in cells that had been treated with an FAK inhibitor, consistent with the SEM findings in Fig-
ure 6—figure supplement 1.
Figure 4 continued
647N–labeled streptavidin (red) and Alexa Fluor 488–labeled [15N]ALO-D4 (green). Cells were then fixed with 3% PFA and imaged by super-resolution
stimulated emission depletion (STED) microscopy. Streptavidin and ALO-D4 bound to the macrophages as well as the lawn of particles on the
surrounding substrate. Scale bar, 5 mm. (B) Biotinylated macrophage particles can be detected with streptavidin-conjugated gold nanoparticles, as
judged by scanning electron microscopy (SEM). After biotinylating the plasma membrane of mouse peritoneal macrophages with Sulfo-NHS-SS-biotin,
cells were plated onto glass-bottom Petri dishes. On the following day, the cells were incubated with streptavidin-conjugated 40-nm gold
nanoparticles. Cells were then fixed with 1% glutaraldehyde and processed for SEM. Secondary electron (SE) and backscattered electron (BSE) images
revealed gold nanoparticles on the macrophage cell body, filopodia, and on macrophage particles that had been released onto the substrate. Higher
magnification images of the blue and yellow boxes are shown on the right. Composite images (gray, SE; red, BSE) images show colocalization of gold
nanoparticles with the particles on the substrate. Higher magnification image of the white box is shown on the right. White arrows point to gold
nanoparticles binding to macrophage particles. Three independent experiments were performed; representative images are shown. Scale bar, 1 mm.
DOI: https://doi.org/10.7554/eLife.50231.016
The following figure supplements are available for figure 4:
Figure supplement 1. Particles released from non-biotinylated macrophages do not bind streptavidin-conjugated gold nanoparticles as judged by
scanning electron microscopy (SEM).
DOI: https://doi.org/10.7554/eLife.50231.017
Figure supplement 2. Correlative SEM and NanoSIMS imaging of macrophages and plasma membrane–derived particles on the surrounding
substrate.
DOI: https://doi.org/10.7554/eLife.50231.018
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In related experiments, we examined macrophages that had been incubated with latrunculin A
for 1 hr in suspension and subsequently plated on poly-D-lysine–coated silicon wafers and incubated
in drug-containing medium for 24 hr (‘pre-treatment’). Because latrunculin A blocks particle release
from macrophages, neither ALO-D4 nor OlyA detected particles on the substrate around macro-
phages (Figure 6—figure supplement 2). However, when latrunculin A was added to the medium
after allowing the cells to adhere to the substrate (‘post-adherence’), a circumferential ring of ALO-
D4 binding, but not OlyA binding, was observed on the substrate surrounding macrophages (Fig-
ure 6—figure supplement 2), corresponding to the circumferential ring of particles detected by
SEM in Figure 2A. In cells treated with DMSO alone, we observed ALO-D4, but not OlyA, binding
to the lawn of particles around macrophages (Figure 6—figure supplement 2), similar to the results
in Figure 6.
We suspected that the binding of lysenin (a cytolysin that binds sphingomyelin) would bind only
weakly to the lawn of particles surrounding macrophages (resembling the findings with OlyA).
Indeed, fluorescence microscopy of macrophages that had been incubated with Alexa Fluor 488–
labeled [15N]ALO-D4 and mCherry-tagged lysenin (which binds sphingomyelin) revealed avid bind-
ing of ALO-D4, but not mCherry-tagged lysenin, to the lawn of particles surrounding macrophages
Figure 5. Enrichment in focal adhesion proteins in the particle preparations from RAW 264.7 macrophages. The most abundant proteins (the top 75th
percentile by spectral counts) were analyzed by Enrichr and categorized by GO Cellular Components 2018. (A–B) Analysis of proteins in macrophage
particles (n = 653) and macrophage plasma membranes (n = 715) by GO categories. The top 10 cellular component categories were ordered by level of
statistical significance. (C) Venn diagram depicting numbers of proteins present in the particle preparation only, the plasma membrane preparation
only, or both. (D) Bar graph showing the top 15 focal adhesion–related proteins by the normalized spectral abundance factor (NSAF), multiplied by
10,000. The particle fraction is shown in blue; the plasma membrane fraction is shown in orange. The bar graph shows the mean ± SD for three
independent experiments. *p<0.05; **p<0.001.
DOI: https://doi.org/10.7554/eLife.50231.019
The following figure supplement is available for figure 5:
Figure supplement 1. Isolation of particles released onto the substrate by RAW 264.7 macrophages.
DOI: https://doi.org/10.7554/eLife.50231.020
Hu et al. eLife 2019;8:e50231. DOI: https://doi.org/10.7554/eLife.50231 8 of 26
Research article Biochemistry and Chemical Biology Cell Biology
(Figure 6—figure supplement 3). When macrophages or CHO cells were treated with sphingomyeli-
nase, the binding of OlyA and lysenin to cells was markedly reduced or abolished (Figure 6—figure
supplement 4).
Next, we performed correlative live-cell, SEM, and NanoSIMS imaging, with the goal of compar-
ing [15N]ALO-D4 and [13C]OlyA binding to the lawn of particles outside macrophages. The live-cell
imaging allowed us to visualize the projection and retraction of lamellipodia (Figure 7—videos 1–
2), and the SEMs revealed the expected lawn of particles outside cells (Figure 7, Figure 7—figure
Figure 6. Particles released by mouse peritoneal macrophages onto the surrounding substrate are enriched in accessible cholesterol but not
sphingomyelin-sequestered cholesterol. Mouse peritoneal macrophages were plated onto poly-D-lysine–coated glass coverslips and incubated
overnight in medium containing 10% FBS and either an FAK inhibitor (CAS 4506-66-5, 2 mM) or vehicle (DMSO) alone. On the next day, the cells were
incubated with Alexa Fluor 488–labeled [15N]ALO-D4 (green), which binds to accessible cholesterol, and Atto 647N–labeled [13C]OlyA (red), which binds
to sphingomyelin-bound cholesterol (both at 20 mg/ml). Cells were then washed, fixed with 3% PFA, and imaged by STED microscopy. STED images
were obtained from the bottom of the macrophage (optical section of ~200 nm). The lawn of particles surrounding macrophages was readily detectable
with ALO-D4, but the binding of OlyA to particles was negligible. Two independent experiments were performed; representative images are shown.
Scale bar, 5 mm. Higher magnification images of the boxed regions are shown on the right. Scale bar, 2 mm.
DOI: https://doi.org/10.7554/eLife.50231.021
The following video and figure supplements are available for figure 6:
Figure supplement 1. Inhibiting focal adhesion kinase in mouse peritoneal macrophages is accompanied by large lawns of particles on the
surrounding substrate.
DOI: https://doi.org/10.7554/eLife.50231.022
Figure supplement 2. Incubating mouse peritoneal macrophages with latrunculin A alters the distribution of ALO-D4 binding.
DOI: https://doi.org/10.7554/eLife.50231.023
Figure supplement 3. Particles released by mouse peritoneal macrophages are enriched in accessible cholesterol but not in sphingomyelin.
DOI: https://doi.org/10.7554/eLife.50231.024
Figure supplement 4. Sphingomyelinase treatment reduces OlyA and lysenin binding to the plasma membrane.
DOI: https://doi.org/10.7554/eLife.50231.025
Figure 6—video 1. Movement of mouse peritoneal macrophages under different experimental conditions.
DOI: https://doi.org/10.7554/eLife.50231.026
Figure 6—video 2. Shows macrophages treated with an FAK inhibitor.
DOI: https://doi.org/10.7554/eLife.50231.027
Figure 6—video 3. Shows acLDL-loaded macrophages treated with vehicle (DMSO) alone.
DOI: https://doi.org/10.7554/eLife.50231.028
Figure 6—video 4. Shows acLDL-loaded macrophages treated with an FAK inhibitor.
DOI: https://doi.org/10.7554/eLife.50231.029
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Figure 7. Correlative live-cell, SEM, and NanoSIMS imaging of mouse peritoneal macrophages, demonstrating that particles released onto the
substrate during movement of filopodia and lamellipodia are enriched in accessible cholesterol but not sphingolipid-sequestered cholesterol.
Macrophages were plated onto iridium- and poly-D-lysine–coated gridded glass-bottom Petri dishes, and videos of cell movement were recorded for
24 h at 5-min intervals (see Figure 7—video 1). The red arrow in the video points to an area of lamellipodia projection/retraction; the white box depicts
the area that was later visualized by SEM and NanoSIMS. The ’Live cell’ image in this figure shows the final frame of the video. After live-cell imaging,
the cells were then incubated with [15N]ALO-D4 (which binds to accessible cholesterol) and [13C]OlyA (which binds to sphingomyelin-sequestered
cholesterol). The cells were then imaged by SEM (to visualize particles) and then by NanoSIMS to visualize [15N]ALO-D4 and [13C]OlyA binding. The
NanoSIMS images were created from secondary ions released from the top of the macrophage plasma membrane and the surrounding macrophage
particles. Thus, the image differs from confocal fluorescence images in Figure 6, where we focused on the bottom surface of the macrophage (optical
section of ~200 nm). The particles released onto the substrate were enriched in accessible cholesterol but not sphingomyelin-sequestered cholesterol.
12C14N– images were useful for cell morphology; 15N/14N images depict binding of [15N]ALO-D4; 13C/12C images depict binding of [13C]OlyA. Here, the
13C/12C and 15N/14N scales were adjusted for visualization of macrophage-derived particles. Additional NanoSIMS images of this cell, with different
scales, are shown in Figure 8A. Two independent experiments were performed; representative images are shown. Scale bar, 5 mm.
DOI: https://doi.org/10.7554/eLife.50231.030
The following video and figure supplements are available for figure 7:
Figure supplement 1. Correlative live-cell, SEM, and NanoSIMS imaging of mouse peritoneal macrophages, demonstrating that particles released
onto the substrate during movement of filopodia and lamellipodia are enriched in accessible cholesterol but not sphingolipid-bound cholesterol.
DOI: https://doi.org/10.7554/eLife.50231.031
Figure supplement 2. Correlative SEM and NanoSIMS imaging, demonstrating that particles released onto the substrate by macrophages are enriched
in accessible cholesterol but not sphingolipid-bound cholesterol.
DOI: https://doi.org/10.7554/eLife.50231.032
Figure supplement 3. The binding of fluorescently labeled OlyA to the plasma membrane overlaps the staining of the actin cytoskeleton with
phalloidin.
DOI: https://doi.org/10.7554/eLife.50231.033
Figure 7 continued on next page
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supplements 1–2). NanoSIMS images revealed that [15N]ALO-D4 bound strongly to the lawn of par-
ticles around macrophages; 15N enrichment was ~twofold higher in the lawn of particles than over
the cell body (Figure 8D). 13C enrichment in the lawn of particles (from [13C]OlyA binding) was very
low (Figures 7 and 8D, Figure 7—figure supplements 1–2). We also observed differences in the
patterns of [15N]ALO-D4 and [13C]OlyA binding to the cell body. In the case of [15N]ALO-D4, we
observed a fine linear band of 15N enrichment at the extreme outer edge of the cell (~40% greater
15N enrichment than over the cell body) (Figures 7 and 8B–D, Figure 7—figure supplements 1–
2). In the case of [13C]OlyA, a broad band of 13C enrichment was observed close to the outer edge
of the cell (~60% higher 13C enrichment than over the main body of the cell) (Figures 7 and 8B–
D, Figure 7—figure supplements 1–2). The broad band of 13C enrichment corresponded to the
lamellipodia of macrophages, visible in the SEM images (Figure 7, Figure 7—figure supplements
1–2) as well as in the 12C–, 12C14N–, and 32S– NanoSIMS images (Figure 8A). By confocal micros-
copy, the binding of OlyA at the outer edge of the cell overlapped with the binding of phalloidin to
the actin cytoskeleton–rich lamellipodia (Figure 7—figure supplement 3). Interestingly, the fine lin-
ear band of 15N enrichment at the outer edge of the cell extended beyond the broad band of 13C
enrichment, as shown by composite images formed from 15N/14N and 13C/12C ratio images
(Figure 8B–C). We also performed correlative live-cell/SEM/NanoSIMS studies with macrophages
that had been incubated with an FAK inhibitor (Figure 7—figure supplements 4–6, Figure 7—vid-
eos 3–4). The FAK inhibitor did not induce any changes to the patterns of [15N]ALO-D4 and [13C]
OlyA binding to particles on the substrate or the macrophage cell body (Figure 7—figure supple-
ment 4–6).
The fact that macrophages release cholesterol-rich particles inspired us to explore whether the
efflux of [3H]cholesterol from [3H]cholesterol-loaded macrophages would be reduced when the
release of particles was blocked with blebbistatin. To test this possibility, [3H]cholesterol-loaded
macrophages were plated on 6-well plates and incubated in serum-free medium (i.e., no cholesterol
acceptors) containing blebbistatin, an LXR agonist, or vehicle (DMSO) alone. After 24 hr, both the
macrophages and macrophage-derived particles on the substrate were released with 5 mM EDTA.
Both macrophage and particle fractions were prepared, and [3H]cholesterol was quantified by scintil-
lation counting. Compared with cells that had been incubated with DMSO alone, more [3H]choles-
terol was retained within the blebbistatin-treated macrophages (Figure 8—figure supplement 1A),
and there was less [3H]cholesterol in the particle fraction (Figure 8—figure supplement 1B). The
LXR agonist had the opposite effect, reducing the amount of [3H]cholesterol in macrophages and
increasing the amount of [3H]cholesterol in the particle fraction (Figure 8—figure supplement 1A–
Figure 7 continued
Figure supplement 4. Correlative live-cell, SEM, and NanoSIMS imaging of mouse peritoneal macrophages treated with an FAK inhibitor,
demonstrating that particles released onto the substrate during movement of filopodia and lamellipodia are enriched in accessible cholesterol but not
sphingolipid-bound cholesterol.
DOI: https://doi.org/10.7554/eLife.50231.034
Figure supplement 5. Correlative live-cell, SEM, and NanoSIMS imaging of mouse peritoneal macrophages treated with an FAK inhibitor,
demonstrating that particles released onto the substrate during movement of filopodia and lamellipodia are enriched in accessible cholesterol but not
sphingolipid-bound cholesterol.
DOI: https://doi.org/10.7554/eLife.50231.035
Figure supplement 6. Correlative SEM and NanoSIMS imaging, demonstrating that particles released onto the substrate by macrophages treated with
an FAK inhibitor are enriched in accessible cholesterol but not sphingolipid-bound cholesterol.
DOI: https://doi.org/10.7554/eLife.50231.036
Figure 7—video 1. Macrophage release particles during movement of filopodia and lamellipodia movement.
DOI: https://doi.org/10.7554/eLife.50231.037
Figure 7—video 2. Shows a macrophage treated with vehicle (DMSO) imaged by SEM and NanoSIMS in Figure 7—figure supplement 2.
DOI: https://doi.org/10.7554/eLife.50231.038
Figure 7—video 3. Shows a macrophage treated with an FAK inhibitor imaged by SEM and NanoSIMS in Figure 7—figure supplement 4.
DOI: https://doi.org/10.7554/eLife.50231.039
Figure 7—video 4. Shows a macrophage treated with an FAK inhibitor imaged by SEM and NanoSIMS in Figure 7—figure supplement 5.
DOI: https://doi.org/10.7554/eLife.50231.040
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Figure 8. Distribution of distinct pools of cholesterol in the macrophage plasma membrane. Mouse peritoneal macrophages were plated onto poly-D-
lysine–coated MatTek dishes and incubated in medium containing 10% FBS. On the next day, cells were incubated with [15N]ALO-D4 and [13C]OlyA (20
mg/ml each) and then imaged by NanoSIMS. (A) Distributions of [15N]ALO-D4 and [13C]OlyA binding to the plasma membrane. 13C/12C NanoSIMS
images revealed a broad band of 13C enrichment near the outer edge of the cell (corresponding to the flat lamellipodia of cells, apparent in the 12C–,
Figure 8 continued on next page
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B). As an additional control, we tested whether adding HDL to the culture medium would increase
[3H]cholesterol efflux from [3H]cholesterol-loaded macrophages. As expected, HDL markedly
increased efflux of [3H]cholesterol into the cell culture medium (Figure 8—figure supplement 2).
Macrophages release cholesterol-rich particles onto a collagen matrix
and onto dead cells
We also plated biotinylated mouse peritoneal macrophages onto glass-bottom MatTek dishes that
were coated with polymerized collagen IV. The macrophages released biotinylated particles, detect-
able with streptavidin-conjugated 40-nm gold nanoparticles, onto the collagen fibers (Figure 9A,
Figure 9—figure supplement 1). To test whether the particles were enriched in accessible choles-
terol, we plated biotinylated macrophages onto glass coverslips coated with PFA-fixed Alexa Fluor
647–labeled collagen IV and then incubated the cells with Alexa Fluor 488–labeled ALO-D4 and
Alexa Fluor 568–labeled streptavidin. By STED microscopy, binding of ALO-D4 to the lawn of par-
ticles on the collagen matrix surrounding macrophages colocalized with streptavidin binding
(Figure 9B). The amount of collagen beneath the lawn of particles was depleted, likely reflecting
digestion of the collagen IV by the filopodia/lamellipodia of the macrophage.
Macrophages also release particles onto dead cells. By live-cell microscopy, we observed a live
macrophage ‘carrying’ a dead macrophage, allowing us to observe the projection and retraction of
lamellipodia/filopodia over the surface of the dead macrophage (Figure 10—video 1). We then
imaged the cells by SEM. By SEM, we observed release of particles onto both the substrate sur-
rounding the live macrophage and to the surface of the dead macrophage (Figure 10—figure sup-
plement 1). In follow-up studies, we plated biotinylated macrophages onto a confluent monolayer
of dead endothelial cells (fixed with 0.1% glutaraldehyde). As expected, we observed binding of
streptavidin-conjugated gold nanoparticles to the cell body and filopodia of macrophages; however,
we also observed binding of streptavidin-conjugated gold nanoparticles to the surface of adjacent
endothelial cells (Figure 10). Although we could easily find gold nanoparticles on the endothelial
cells in these studies, we were unable to identify with confidence macrophage-derived membrane
particles on the surface of endothelial cells (because of the complicated topography of the plasma
membrane of glutaraldehyde-fixed endothelial cells). Nevertheless, the distribution of gold
Figure 8 continued
12C14N–, and 32S– NanoSIMS images). The 15N/14N images revealed a thin band of 15N enrichment at the far outer edge of the cells and in the lawn of
particles on the surrounding substrate. Additional NanoSIMS images of these cells are shown (with different scales) in Figure 7 and Figure 7—figure
supplement 1. (B) Composite 12C14N– (blue), 13C/12C (green), and 15N/14N (red) NanoSIMS images, revealing 15N enrichment at the outer edge of the
plasma membrane and in the lawn of particles on the surrounding substrate. Of note, the 15N enrichment at the outer edge of the cell extended
beyond the thick band of 13C enrichment. In this figure, the scales for the 13C/12C and 15N/14N NanoSIMS images were adjusted for optimal
visualization of the lamellipodia of macrophages. Also, 12C– and 32S– images were included to visualize the lamellipodia. Scale bar, 5 mm. Additional
NanoSIMS images of the cell in the top row of this panel are shown in Figure 8A and Figure 7—figure supplement 1; additional NanoSIMS images of
the cell in the bottom row of this panel is shown in Figure 7—figure supplement 2. Two independent experiments were performed; representative
images are shown. (C) Line scans comparing the 15N/14N and 13C/12C isotope ratios over the outer edge of the plasma membrane (white line in the
upper and lower right images of panel B). (D) Quantification, by NanoSIMS, of [15N]ALO-D4 and [13C]OlyA binding to macrophages and to the
surrounding particles on the substrate. 15N/14N ratios were quantified for the cell body, macrophage-derived particles, and the thin line of 15N
enrichment at the edge of the cell. 13C/12C ratios were quantified for the cell body, macrophage particles, and the broad lamellipodia near the edge of
the plasma membrane. For each category, twenty-five regions, 20 pixels in diameter areas were circled on the 12C14N– images, and the 15N/14N and
13C/12C ratios in each circle were calculated. A minimum of six macrophage images were used. Graph shows the mean and standard deviation of the
fold change of 15N or 13C enrichment, normalized to the macrophage cell body. **p<0.001.
DOI: https://doi.org/10.7554/eLife.50231.041
The following figure supplements are available for figure 8:
Figure supplement 1. Reduced efflux of [3H]cholesterol from [3H]cholesterol-loaded macrophages when the release of particles was blocked with
blebbistatin.
DOI: https://doi.org/10.7554/eLife.50231.042
Figure supplement 2. Increased efflux of [3H]cholesterol from [3H]cholesterol-loaded macrophages in the presence of HDL.
DOI: https://doi.org/10.7554/eLife.50231.043
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Figure 9. Mouse peritoneal macrophages release accessible cholesterol–enriched particles onto a polymerized collagen IV matrix. After biotinylating
the cell-surface proteins of macrophages with Sulfo-NHS-SS-biotin, the cells were plated onto glass-bottom Petri dishes that had been coated with
polymerized Alexa Fluor 647–labeled collagen IV and then fixed with 0.1% glutaraldehyde (for SEM) or 1% paraformaldehyde (for fluorescence
microscopy). (A) SEM images show binding of streptavidin-conjugated 40-nm gold nanoparticles to macrophages as well as particles on the collagen IV
substrate. Secondary electron (SE) and backscattered electron (BSE) images show macrophage-derived particles on the collagen fibers and the binding
of gold nanoparticles to the macrophage cell body, filopodia, and the plasma membrane–derived particles. BSE images were helpful to identify gold
nanoparticles. Higher magnification images of the yellow and blue boxed regions are shown on the right. Scale bar, 2 mm. (B) Fluorescent microscopy
studies of mouse peritoneal macrophages that had been plated for 24 hr on a polymerized Alexa Fluor 647–labeled collagen IV substrate and then
incubated with Alexa Fluor 488–labeled ALO-D4 and Alexa Fluor 568–labeled streptavidin. The cells were then fixed with 3% PFA and images recorded
by STED microscopy. ALO-D4 (green) and streptavidin (blue) were visualized on a lawn of particles on the collagen IV matrix (red). Four independent
experiments were performed; representative images are shown. Scale bar, 5 mm.
DOI: https://doi.org/10.7554/eLife.50231.044
The following figure supplement is available for figure 9:
Figure supplement 1. Mouse peritoneal macrophages release particles onto a polymerized collagen IV matrix.
DOI: https://doi.org/10.7554/eLife.50231.045
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Figure 10. Biotinylated mouse peritoneal macrophages release plasma membrane–derived material onto the surface of dead endothelial cells. Mouse
brain endothelial cells (bEnd.3) were plated onto glass- bottom Petri dishes and allowed to grow to confluency. After fixing the endothelial cells with
0.1% glutaraldehyde in PBS, they were washed extensively with PBS. Next, biotinylated macrophages (i.e., macrophages in which the cell-surface
proteins had been biotinylated with Sulfo-NHS-SS-biotin) were plated onto bEnd.3 cells. Secondary electron (SE) and backscattered electron (BSE)
images were obtained with a scanning electron microscope. As expected, the SEM images revealed binding of the streptavidin- conjugated gold
nanoparticles to both the cell body and filopodia of macrophages. In addition, gold nanoparticles were observed on the surface of adjacent endothelial
cells. BSE images were helpful in identifying gold nanoparticles. Higher magnification images of the blue and red boxed regions in each image are
shown below. As an experimental control, bEnd.3 cells without macrophages were fixed and incubated with streptavidin-conjugated gold
nanoparticles. Higher magnification images of the red boxed regions are shown on the right. No binding of gold nanoparticles was detected. Three
independent experiments were performed; representative images are shown. Scale bar, 2 mm.
DOI: https://doi.org/10.7554/eLife.50231.046
The following video and figure supplement are available for figure 10:
Figure 10 continued on next page
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nanoparticles on the endothelial cells (adjacent to one pole of the macrophage) suggested that
plasma membrane–derived biotinylated particles had been released onto the surface of endothelial
cells.
Discussion
In the current studies, we gleaned two insights into the genesis and composition of the ~30-nm
vesicular particles that are released by cultured macrophages onto the surrounding substrate. First,
we showed that particles are released from the macrophage plasma membrane during the projec-
tion and retraction of filopodia and lamellipodia. When the movement of filopodia/lamellipodia was
blocked by actin depolymerization (latrunculin A) or by inhibiting myosin II (blebbistatin), particle
release was abolished. Also, the deposition of particles onto the substrate occurred only in sites
where we had observed (by live-cell microscopy) the projection and retraction of filopodia and lamel-
lipodia. These findings implied that the particles were fragments of the plasma membrane that had
been anchored to the substrate but subsequently torn away and left behind during the projection
and retraction of filopodia/lamellipodia. Particles were also left behind as adherent macrophages
progressively retracted during latrunculin A–induced depolymerization of the actin cytoskeleton. The
fact that macrophage particles contained proteins associated with the plasma membrane, including
adhesion complex proteins and cytoskeletal proteins, is consistent with the conclusion that the par-
ticles are plasma membrane fragments left behind during cellular locomotion. Second, we found
that the plasma membrane–derived particles were enriched in ‘accessible cholesterol’ but not in
sphingolipid-sequestered cholesterol. By super-resolution fluorescence microscopy and NanoSIMS
imaging, we found robust binding of ALO-D4 (specific for the accessible pool of cholesterol) to the
lawn of particles around macrophages. In contrast, there was minimal binding of OlyA, which binds
to the sphingolipid-sequestered pool of cholesterol in the plasma membrane.
Our studies with biotinylated macrophages provided further evidence that the particles on the
surrounding substrate are derived from the plasma membrane. After an overnight incubation, the
lawn of particles around macrophages was readily detectable with fluorescently labeled streptavidin.
Also, we observed binding of streptavidin-conjugated gold nanoparticles to the particles on the sub-
strate around macrophages. Immunocytochemistry studies designed to detect specific plasma mem-
brane proteins on the lawn of particles were inconclusive, very likely because of the low abundance
of any given protein within a particle and because the binding affinities of most antibodies are far
lower than the affinity of streptavidin for biotin.
We observed particularly large lawns of particles around macrophages that had been treated
with an FAK inhibitor, which interferes with the disassembly of focal adhesions (the macromolecular
complexes that tether cells to the underlying substrate). It makes sense that inhibiting focal adhesion
disassembly would increase the likelihood of plasma membrane fragments being left behind during
cellular locomotion. However, even though the lawn of particles surrounding FAK inhibitor–treated
macrophages was consistently larger in multiple experiments, we are hesitant to draw ironclad con-
clusions, simply because we have not yet developed a realistic and practical strategy for accurately
quantifying numbers of particles in the ‘lawn’ surrounding an individual macrophage (let alone the
numbers of particles surrounding large numbers of macrophages on a cell culture plate).
In our studies, the particles on the substrate surrounding macrophages were enriched (relative to
the plasma membrane over the cell body) in accessible cholesterol but depleted in sphingomyelin-
sequestered cholesterol. This finding was evident by both fluorescence microscopy and NanoSIMS
Figure 10 continued
Figure supplement 1. Correlative live-cell and SEM images, revealing the release of particles by a live macrophage onto the surface of a dead
macrophage.
DOI: https://doi.org/10.7554/eLife.50231.047
Figure 10— video 1. Release of vesicular particles by a live RAW 264.7 macrophage onto the surrounding substrate and onto a dead RAW 264.7
macrophage.
DOI: https://doi.org/10.7554/eLife.50231.048
Hu et al. eLife 2019;8:e50231. DOI: https://doi.org/10.7554/eLife.50231 16 of 26
Research article Biochemistry and Chemical Biology Cell Biology
imaging. Why the lawn of particles would be enriched in the accessible pool of cholesterol has not
been established in an unequivocal fashion, but we would propose a potential explanation—one
stimulated from the observations by Raghupathy and coworkers (Raghupathy et al., 2015) on the
role of the cytoskeleton in organizing plasma membrane lipids. They proposed that the actin cyto-
skeleton is tethered, through adaptor proteins, to long acyl-chain–containing phosphatidylserines in
the cytoplasmic leaflet of the plasma membrane, which interact with microdomains on the outer leaf-
let containing cholesterol and long acyl-chain–containing lipids (e.g., sphingolipids). According to
this model, sphingolipid-associated cholesterol on the outer leaflet of the plasma membrane associ-
ates, indirectly, with the actin cytoskeleton and thus would presumably remain tethered to the actin
cytoskeleton during movement of filopodia and lamellipodia. According to this model, the non-
sequestered ‘accessible’ pool of cholesterol, which is known to be mobile (Infante and Radhak-
rishnan, 2017), would be more likely than the sphingolipid-sequestered cholesterol to be left behind
on the substrate during the movement of filopodia/lamellipodia. Our NanoSIMS images of [15N]
ALO-D4 and [13C]OlyA binding are consistent with this model. We observed broad bands of 13C
enrichment along the perimeter of macrophages, corresponding to the broad, flat, actin cytoskele-
ton–rich lamellipodia, but there was minimal 13C enrichment in the lawn of particles surrounding
cells. In contrast, both the lawn of particles on the substrate as well as the extreme edge of the mac-
rophage plasma membrane (from which particles are released) were enriched in 15N. The thin linear
band of 15N enrichment at the far edge of the cell extends beyond the broad band of [13C]OlyA
binding. Thus, the plasma membrane at the far edge of the cell is enriched in accessible cholesterol.
Presumably, the negligible amounts of 13C enrichment in the lawn of particles around macrophages
is explained by the low amounts of 13C within the thin 15N-enriched region at the far edge of the
plasma membrane.
We found that macrophages release, during movement of filopodia and lamellipodia, large num-
bers of ~30-nm ‘accessible cholesterol’–rich particles onto the substrate. In earlier studies, other
groups have uncovered evidence for the release of membranous fragments during cell migration.
For example, Schmidt et al. (1993) described the ripping away of integrin-containing, cytoskeletal
element–free membranous particles from rat fibroblasts during cell migration, but those particles
(visible by light microscopy) were larger than we observed by SEM around cultured macrophages.
Regen and Horwitz (1992) described release of trails of membranous particles from migrating
chicken fibroblasts, but again, the particles were larger than we observed in macrophages. In these
studies, the cholesterol content of particles was not investigated. Vedhachalam et al. (2007) pro-
vided suggestive electron microscopy evidence for the protrusion of cholesterol-rich exovesicular
domains from the surface of J774 macrophages, but they did not describe the release of vesicular
particles from those cells. They proposed that the exovesicular protrusions contained ABC transport-
ers and were involved in the efflux of cholesterol onto apolipoprotein AI molecules in the biogenesis
of HDL. Most recently, Li Yu’s group described release of ‘migrasomes’ from filopodia in a variety of
cell lines during cell migration (Ma et al., 2015; Huang et al., 2019). Migrasomes were described as
cholesterol-rich micron-sized structures that, by electron microscopy, contained multiple 50–100-nm
vesicular structures. Migrasome formation was blocked by cholesterol depletion. They did not
describe ‘lawns’ of ~30-nm particles on the substrate surrounding their cultured cells. In our studies,
we did not observe structures resembling migrasomes within the filopodia of cultured macrophages.
Also, in an earlier study (He et al., 2018), we observed lawns of particles surrounding macrophages
even after depleting the cells of cholesterol with an overnight incubation with HDL.
Our studies revealed that cultured macrophages release large numbers of cholesterol-rich par-
ticles onto a poly-D-lysine-coated substrate, but whether macrophages in living tissues release cho-
lesterol-rich particles in the same manner has not yet been established. Detecting the release of
plasma membrane–derived particles in vivo will be extremely challenging, in part because it will be
very difficult to distinguish plasma membrane–derived particles from plasma lipoproteins and other
membrane-bound particles (e.g., exosomes). However, we did find that macrophages are capable of
releasing plasma membrane–derived particles onto more physiologic substrates (e.g., collagen
matrix, dead cells), lending plausibility to the notion that particle release could occur in vivo. Particle
release by macrophages in vivo could be relevant to cholesterol homeostasis. In terms of normal
cholesterol physiology, it is conceivable that particle release could contribute to reverse cholesterol
transport. In support of this idea, the release of [3H]cholesterol by macrophages (incubated in the
absence of cholesterol acceptors) was reduced by abolishing particle release with blebbistatin. An
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earlier study (He et al., 2018) revealed that HDL is effective in depleting cholesterol from plasma
membrane–derived particles. Thus, particle release could facilitate the return of accessible choles-
terol into the circulation. In terms of disease, the release of cholesterol-rich membrane particles onto
matrix proteins in the interstitial spaces of the arterial wall could, over a period of many years, con-
tribute to the accumulation of extracellular cholesterol in atherosclerotic plaques.
Materials and methods
Key resources table
Reagent type
(species) or
resource Designation Source or reference Identifiers
Additional
information
Cell line
(M. musculus)
RAW 264.7 ATCC Catalog No. TIB-71
RRID: CVCL_0493
Cell line
(M. musculus)
bEnd.3 ATCC Catalog No. CRL-2299
RRID: CVCL_0170
Recombinant
DNA reagent
ALO-D4 plasmid PMID: 25809258 Dr. Arun Radhakrishnan
(UT Southwestern)
Recombinant
DNA reagent
OlyA plasmid PMID: 30712872 Dr. Arun Radhakrishnan
(UT Southwestern)
Chemical
compound, drug
N-(3-Dimethylaminopropyl)-N0-
ethylcarbodiimide hydrochloride
(carbodiimide)
Millipore-Sigma Catalog No. 03449
Chemical
compound, drug
Glutaraldehyde
25% solution
Electron Microscopy
Sciences
Catalog No. 16220
Chemical
compound, drug
Osmium tetroxide
4% solution
Electron Microscopy
Sciences
Catalog No. 18459
Chemical
compound, drug
Paraformaldehyde
16% solution
Electron Microscopy
Sciences
Catalog No. 15170
Chemical
compound, drug
EMbed 812 Electron Microscopy
Sciences
Catalog No. 14120
Chemical
compound, drug
Sodium cacodylate
trihydrate
Electron Microscopy
Sciences
Catalog No. 12300
Chemical
compound, drug
Uranyl acetate SPI-Chem Catalog No. 02624AB
Chemical
compound, drug
Latrunculin A Sigma Catalog No.
L5163
Chemical
compound, drug
Blebbistatin Abcam Catalog No.
ab120425
Chemical
compound, drug
FAK inhibitor Calbiochem Catalog No.
CAS 4506-66-5
Chemical
compound, drug
LXR agonist Sigma Catalog No.
G6295
Chemical
compound, drug
HDL Alfa Aesar Catalog No.
J64903
Chemical
compound, drug
[3H]cholesterol PerkinElmer Catalog No.
NET139250UC
Chemical
compound, drug
Gold–streptavidin
conjugation reagent
Abcam Catalog No.
ab186864
Chemical
compound, drug
EZ-Link Sulfo-
NHS-SS-biotin
ThermoFisher Catalog No.
21331
Chemical
compound, drug
Sphingomyelinase from
Staphylococcus aureus
Sigma Catalog No.
S8633
Other 35 mm glass-bottom
gridded MatTek dish
MatTek Catalog No.
P35G-1.5–14-CGRD
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Mouse peritoneal macrophages
Wild-type C57BL/6 mice were injected intraperitoneally with 1 ml of 3% Difco Fluid Thioglycollate
Medium (Becton Dickinson). Three days later, macrophages were harvested by peritoneal lavage
with 10 ml of Dulbecco’s Phosphate Buffered Saline (PBS). Cells were centrifuged at 400  g for 5
min at 4˚C, incubated with red blood cell lysing buffer (Sigma), and washed two times with cold PBS.
Macrophages were plated onto fetal bovine serum (FBS)-coated Petri dishes (8  106 cells/dish) and
incubated overnight in macrophage growth medium [Dulbecco’s Minimal Eagle Medium (Gibco)
supplemented with 1% sodium pyruvate and 1% glutamine] containing 10% FBS (Gemini GemCell).
On the following day, macrophages were released from the dish by incubating the cells with PBS
containing 5 mM ethylenediaminetetraacetic acid (EDTA) for 30 min at 4˚C. For fluorescence micros-
copy, cells were plated onto glass coverslips in 24-well plates (75,000 cells/well). For scanning elec-
tron microscopy (SEM) and NanoSIMS studies, cells were plated onto 0.5 cm2 silicon wafers in 24-
well plates (75,000 cells/well). All substrates were sterilized and coated with 0.1 mg/ml of poly-D-
lysine (Sigma).
Preparation of ALO-D4 and OlyA
ALO-D4 and OlyA were produced in Escherichia coli using plasmids from Dr. Arun Radhakrishnan
(UT Southwestern) (Gay et al., 2015; Endapally et al., 2019). 15N-labeled ALO-D4 and 13C-labeled
OlyA were prepared as described previously (He et al., 2018; He et al., 2017). Briefly, ALO-D4 and
OlyA were expressed in BL21(DE3) pLysS E. coli (Invitrogen) in 1 L of minimal medium containing
20.2 mM 15NH4Cl (for
15N-labeled ALO-D4) or minimal medium containing 10% D-Glucose-13C6 (for
13C-labeled OlyA) at 18˚C for 16 hr. Expression was induced by adding 1 mM isopropyl b-D-1-thio-
galactopyranoside (IPTG) to the medium. Cells were pelleted, sonicated, and the lysate was centri-
fuged at 4˚C. The supernatant fluid was mixed with 4 ml of HisPur Cobalt resin (50% bed volume;
ThermoFisher). The mixture was loaded into a column and allowed to flow through by gravity. The
column was washed, and [15N]ALO-D4 and [13C]OlyA were eluted with a buffer containing 300 mM
imidazole. Eluates were concentrated to 1 ml with an Amicon 10 kDa cut-off filter (Millipore). The
[13C]OlyA was further purified by gel filtration on a Superdex 200 10/300 column (GE Healthcare).
The purified preparations of [15N]ALO-D4 and [13C]OlyA were stored at 4˚C.
Correlative light microscopy, SEM, and NanoSIMS imaging
35-mm glass-bottom gridded Petri dishes (MatTek) were sputter-coated with ~4 nm of iridium with
an ion-beam sputtering system (South Bay Technologies). Dishes were then washed three times for 5
min with 100% ethanol, air dried, and then coated with 0.1 mg/ml poly-D-lysine overnight at 4˚C. On
the next day, the dish was rinsed three times with sterile water; after drying, peritoneal macrophages
were plated at 50,000 cells/dish. Live-cell videos were captured with a Zeiss LSM800 confocal micro-
scope with a Plan Apochromat 20/0.80 objective. The incubation chamber was maintained at 37˚C
and 5% CO2 with TempModule S1 (Zeiss) and CO2 Module S1 (Zeiss). Images were captured at 5
min intervals for 24 hr. Next, the cells were washed with PBS containing Ca2+ and Mg2+ (PBS/Ca/
Mg) containing 0.2% bovine serum albumin (BSA) three times for 2 min and then incubated with
[15N]ALO-D4 (20 mg/ml in PBS + 0.2% BSA) for 2 hr at 4˚C. In some experiments, [13C]OlyA (20 mg/
ml in PBS + 0.2% BSA) was also included in the medium. Next, cells were washed three times for 2
min with PBS/Ca/Mg + 0.2% BSA and then fixed with 4% paraformaldehyde and 2.5% glutaralde-
hyde (both from Electron Microscopy Sciences) in 0.1 M sodium cacodylate (pH 7.4; Sigma) for 1 hr
on ice. Cells were washed with 0.1 M sodium cacodylate (pH 7.4) three times for 5 min, then fixed
with 2% OsO4 (Electron Microscopy Sciences) in 0.1 M sodium cacodylate on ice for 1 hr. Samples
were rinsed three times for 5 min with distilled water, dehydrated with increasing amounts of etha-
nol (30, 50, 70, 85, 95, and 100%; 3  10 min), and air dried. The glass coverslip attached to the bot-
tom of the Petri dish was removed with Coverglass Removal Fluid (MatTek) and placed onto a pin
stub with Pelco colloidal silver (Ted Pella) and then coated with ~5 nm of iridium. Taking advantage
of the gridded coverglass, the very same cells imaged by live-cell imaging were imaged with a Zeiss
Supra 40VP scanning electron microscope with a 3-KeV incident beam. Next, the same cells were
imaged with a NanoSIMS 50L instrument (CAMECA). Samples were scanned with a 16-KeV 133Cs+
beam, and secondary electrons (SEs) and secondary ions (12C–, 13C–, 12C14N–, 12C15N–, 32S–) were
collected. For NanoSIMS imaging on RAW 264.7 macrophages, a 50  50-mm region of the section
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was pre-sputtered with a ~1-nA beam current (primary aperture D1 = 1) for 26 s (to remove the irid-
ium coating). A 40  40-mm region was imaged with an ~1.3-pA beam current (primary aperture
D1 = 2) and a dwell time of ~2.5 ms/pixel/frame for five frames. 512  512–pixel images were
obtained. For NanoSIMS imaging on peritoneal macrophages, a 25  25-mm region was imaged
with an ~3-pA beam current (primary aperture D1 = 2) and a dwell time of ~0.5 ms/pixel/frame for
18–20 frames. 512  512–pixel images were obtained. Images were prepared with the OpenMIMS
plugin in ImageJ. [The last 15 frames of image sets were used to avoid any possibility of signals from
surface contaminants and coating materials.] 15N/14N and 13C/12C ratios images were used to iden-
tify areas of stable isotope enrichment (from [15N]ALO-D4 and [13C]OlyA binding).
Macrophage particle isolation
RAW 264.7 macrophages were plated onto ten T175 cell culture flasks (Corning) and grown over-
night to ~80% confluency in macrophage growth medium containing 1% lipoprotein-deficient serum
(LPDS; Alfa Aesar). On the next day, cells were washed two times with ice-cold PBS and then incu-
bated for 30 min at 4˚C in PBS containing 10 mM EZ-link Sulfo-NHS-SS-biotin (ThermoFisher). The
biotinylation reaction was stopped with Quenching Buffer (ThermoFisher). Cells were then washed
three times for 5 min with PBS, lifted by incubating the cells in PBS containing 5 mM EDTA, and cen-
trifuged at 300  g for 5 min. The supernatant fluid containing particles was centrifuged again at
3000 g for 10 min to remove membrane debris and subsequently filtered through a 0.22-mm filter.
The cell pellet was sonicated at low power (1.5) on ice for five cycles of 45 s on and 30 s off. The pel-
let was added to PBS containing 250 mM sucrose and centrifuged at 3000  g for 10 min at 4˚C.
The supernatant fluid (containing the particles) and the plasma membrane extracts were incubated
with 1 ml of NeutrAvidin beads (ThermoFisher) for 1 hr at 4˚C. The beads containing particles or
plasma membranes were then loaded onto 2 ml columns, and the samples were allowed to flow
though. The columns were then washed three times (4 ml each) with PBS containing 0.2% Triton
X-100. The particles and plasma membranes were eluted with 500 ml of PBS containing 50 mM
dithiothreitol (DTT).
Negative-stain transmission electron microscopy
PBS containing 50 mM DTT (5 ml) was pipetted directly onto a freshly glow-discharged copper grid
that had been coated with formvar and carbon (Electron Microscopy Sciences); the PBS was then
blotted off with Whatman #1 filter paper. Next, 5 ml of particle preparation, the plasma membrane
preparation, or PBS alone was pipetted onto the grid and allowed to adsorb for 1 min before blot-
ting off with filter paper. Next, 5 ml of 2% uranyl acetate was pipetted onto the grid and blotted off,
followed by another 5 ml of 2% uranyl acetate, which was allowed to incubate for 1 min before being
blotted off. Grids were imaged using an FEI Tecnai T12 set to 120 kV accelerating voltage equipped
with a Gatan 2k  2 k CCD detector.
Drug treatment of cultured macrophages
Thioglycollate-elicited peritoneal macrophages were plated onto FBS-coated Petri dishes in macro-
phage growth medium containing 10% FBS overnight at 37˚C. On the next day, macrophages were
released by incubating the cells with PBS containing 5 mM EDTA. Macrophages were then incubated
for 1 hr in suspension in macrophage growth medium containing 10% FBS and 5 mM latrunculin A
(Sigma), 30 mM blebbistatin (Abcam), or 2 mM focal adhesion kinase (FAK) inhibitor (CAS 4506-66-5;
Calbiochem). All drugs were diluted in DMSO. After 1 hr, macrophages were plated in drug-contain-
ing culture medium onto poly-D-lysine–coated substrates (silicon wafers or glass-bottom MatTek
dishes for SEM and NanoSIMS imaging; glass coverslips for confocal fluorescence microscopy) and
incubated for 24 hr. In some experiments, macrophages were plated onto poly-D-lysine–coated sub-
strate and allowed to adhere for 1 hr in macrophage medium in the absence of drugs. After remov-
ing the medium, the cells were then incubated in drug-containing medium for 24 hr.
Shotgun proteomics
Protein samples were resuspended in 8 M urea in 100 mM Tris, pH 8.5 and reduced, alkylated, and
digested by sequential addition of lys-C and trypsin proteases as described (Kaiser and Wohlschle-
gel, 2005; Wohlschlegel, 2009). The sample was fractionated using reversed-phase
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chromatography and then eluted into a Fusion Lumos tribrid mass spectrometer (ThermoFisher).
MS/MS spectra were collected and analyzed with ProLuCID and DTASelect algorithms (Xu et al.,
2006; Tabb et al., 2002). Database searches were performed against a mouse database. Protein
and peptide identifications were filtered with a false-positive rate of <5%, as judged by a decoy
database strategy. Normalized spectral abundance factor (NSAF) values were calculated as
described (Florens et al., 2006). Analysis of other background contaminants was performed using
CRAPome (Mellacheruvu et al., 2013). Gene-annotation enrichment analyses were performed with
Enrichr (Chen et al., 2013; Kuleshov et al., 2016).
Immunogold SEM studies
Mouse peritoneal macrophages were grown on FBS-coated Petri dishes overnight in macrophage
growth medium containing 10% FBS. On the next day, cells were washed and then released by incu-
bating the cells in PBS containing 5 mM EDTA for 30 min at 4˚C. The cells were washed three times
with PBS before incubating in PBS containing 0.25 mg/ml of Sulfo-NHS-SS-Biotin (ThermoFisher) for
20 min at 4˚C (1.0 ml for each 1  106 cells). Cells were pelleted at 300  g for 5 min and washed
three times with 10 ml of PBS before plating onto glass-bottom MatTek dishes at 50,000 cells/dish.
The cells were incubated for 24 hr in macrophage growth media containing 10% FBS. On the next
day, cells were washed three times with PBS/Ca/Mg and fixed with 4% PFA and 0.1% glutaraldehyde
in PBS for 1 hr at 4˚C. Cells were washed three times for 5 min with PBS/Ca/Mg containing 0.2%
BSA, blocked with blocking buffer [PBS/Ca/Mg containing 5% donkey serum, 5% BSA, and 0.1%
cold water fish skin gelatin (Electron Microscopy Sciences)] for 1 hr at room temperature, and then
incubated with streptavidin-conjugated gold nanoparticles (1/50, diluted in blocking buffer; Abcam)
for 2 hr at 4˚C. The samples were then washed three times with blocking bluffer (5 min each); fixed
with 1% glutaraldehyde in 0.1 M sodium cacodylate for 10 min on ice; washed five times with 0.1 M
sodium cacodylate (2 min each); incubated with 2% osmium tetroxide in 0.1 M sodium cacodylate
for 45 min on ice; washed three times (5 min each) with ice-cold water; and dehydrated with a series
of graded concentrations of ethanol. Secondary electron and backscattered electron images were
recorded with a Zeiss Supra 40VP scanning electron microscope with a 5-KeV incident beam with a
backscatter detector.
Immunocytochemistry of macrophage particles
Peritoneal macrophages were plated onto glass coverslips coated with 0.1 mg/ml poly-D-lysine.
Cells were incubated for 24 hr in macrophage growth medium containing 10% FBS. In some experi-
ments, the 10% FBS in the medium was replaced with 1% LPDS (Alfa Aesar) with or without 50 mg/
ml of acetylated low-density lipoproteins (acLDL, Alfa Aesar). In other experiments, the cells (after
24 hr of growth in medium containing 10% FBS) were treated with sphingomyelinase from Staphylo-
coccus aureus (100 milliunits/ml) for 30 min at 37˚C. On the next day, cells were washed three times
for 5 min with PBS/Ca/Mg containing 0.2% BSA and then incubated for 2 hr at 4˚C with Alexa Fluor
488–labeled [15N]ALO-D4 and Atto 647N–labeled [13C]OlyA (both at 20 mg/ml, diluted in PBS/Ca/
Mg + 0.2% BSA). In some experiments, cells were incubated with Alexa Fluor 488–labeled [15N]ALO-
D4 (20 mg/ml) and Atto 647N–labeled streptavidin (Sigma; 1/100). In other experiments, cells were
incubated with Alexa Fluor 488–labeled [15N]ALO-D4 (20 mg/ml) and an mCherry–lysenin fusion pro-
tein (10 mg/ml). After these incubations, the cells were washed three times for 2 min with PBS/Ca/
Mg containing 0.2% BSA; fixed with 3% PFA; and mounted onto glass slides with Prolong Gold
mounting media (ThermoFisher). Images were recorded with a Leica TCS SP8 STED 3X confocal
microscope using a 100/1.4 objective. Alexa Fluor 488 images were obtained with a 488 nm white
light laser and a 592 nm depletion laser. Atto 647N images were obtained with a 647 nm white light
laser and a 775 nm depletion laser. mCherry images were obtained with a 587 nm white light laser.
Sequential scans were recorded at 2048  2048 pixels.
Plating macrophages on collagen
Collagen IV from human placenta (Sigma) was labeled with an Alexa Fluor 647 fluorophore (Thermo-
Fisher). The fluorescently labeled collagen IV (1 mg/ml) was added to glass-bottom MatTek dishes
on ice. Dishes were incubated overnight at 37˚C and 5% CO2 to induce polymerization. On the next
day, the excess collagen was removed, and the dishes were rinsed three times with PBS before fixing
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the collagen with 0.1% glutaraldehyde in PBS (for SEM) or 1% PFA in PBS (for confocal microscopy)
for 10 min at room temperature. Dishes were washed ten times for 6 min with PBS. Macrophage
were then plated onto the collagen IV–coated dishes (50,000 cell/dish) in macrophage growth
medium containing 10% FBS for 24 hr. On the next day, cells were either incubated with streptavi-
din-conjugated gold nanoparticles for SEM or Alexa Fluor 568–labeled streptavidin and Alexa Fluor
488–labeled [15N]ALO-D4 for confocal fluorescence microscopy.
Immunogold SEM of macrophages plated on fixed endothelial cells
Mouse brain microvascular endothelial cells (bEnd.3; ATCC #CRL-2299) were plated onto glass-bot-
tom MatTek dishes in DMEM (ATCC) containing 10% FBS (ATCC), 1% sodium pyruvate, and 1% glu-
tamine. The cells were allowed to grow to 100% confluency. Next, the cells were rinsed with PBS
and fixed with 0.1% glutaraldehyde in PBS for 10 min at room temperature. Cells were then washed
ten times with PBS (6 min each). Macrophages that had been biotinylated (50,000 cells/dish) were
plated onto the bEnd.3 cells and incubated in macrophage growth medium containing 10% FBS
(Gemini GemCell) for 24 hr. On the next day, the cells were processed for immunogold SEM, as
described earlier.
Efflux of [3H]cholesterol from macrophages
Mouse peritoneal macrophage were plated on FBS-coated Petri dishes overnight in macrophage
growth medium containing 10% FBS. On the next day, cells were washed three time with PBS and
then incubated for 24 hr in macrophage growth medium containing 1% LPDS, [3H]cholesterol (1 mCi/
ml, PerkinElmer), and acetyl-LDL (20 mg/ml). On the following day, cells were washed three times (5
min each) with PBS and then released from the plate with PBS containing 5 mM EDTA. Cells were
then plated onto 6-well plates (1  106 cells/well) and incubated for 24 hr in serum-free macrophage
growth medium containing blebbistatin (30 mM), an LXR agonist (1 mM), or vehicle (DMSO) alone. As
an additional control, the cells in one study were incubated with HDL (20 mg/ml, Alfa Aesar). On the
next day, the medium was removed and saved for scintillation counting. The cells were then washed
three times (5 min each) with PBS and released from the plate with PBS containing 5 mM EDTA.
Cells were pelleted by centrifugation (300  g for 5 min), washed, and resuspended in 500 ml of
PBS. The supernatant fluid was centrifuged again (3000  g for 10 min) to remove debris and then
filtered through a 0.22-mm filter to obtain the particle preparation. Samples of the cells, the particles,
and the medium (100 ml) were mixed with 4 ml of scintillation fluid (Optiphase Hisafe 3), and 3H dpm
were recorded with a scintillation counter.
Cell lines
RAW 264.7 and bEnd.3 cells were obtained from ATCC with proper ‘certificate of analysis’. All cell
lines were negative for mycoplasma contamination.
Statistics
Statistical analyses of data were performed with GraphPad Prism 7.0 software. Quantitative data are
reported as mean ± standard deviation. Differences were assessed with a Student’s t-test with
Welch’s correction.
Study approval
Animal housing and experimental protocols were approved by UCLA’s Animal Research Committee.
The animals were housed in an AAALAC (Association for Assessment and Accreditation of Labora-
tory Animal Care International)-approved facility and cared for according to guidelines established
by UCLA’s Animal Research Committee. The mice were fed a chow diet and housed in a barrier facil-
ity with a 12 hr light-dark cycle.
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